Witty’s second post in as many days

NEVER one to rest on his laurels, former GlaxoSmithKline (GSK) boss Sir Andrew Witty has taken on his second role in as many days.

The 53-year-old, who retired as GSK chief executive this year, was yesterday appointed to the advisory board of Synthego, a leading provider of genome engineering in the US.

He will guide the firm as it extends further into the genome engineering market.

Paul Dabrowski, chief executive of Synthego, said: ‘Andrew’s broad experience in the biopharmaceutical space will help us unlock the full value of our platform and grow in key areas.’

The news came just a day after the pharmaceutical veteran joined US biopharmaceutical firm Hatteras Venture Partners as a venture partner, where he will advise on the company’s strategic positioning.

A keen marathon runner who ran the London Marathon in 2008, Witty lives in Buckinghamshire with his wife, Caroline, and their two children. He was knighted in 2012.